Avicanna Announces Sponsorship of Pilot Phase II Clinical Study Osteoarthritis Pain
Multi-centre, blinded, randomized placebo-controlled investigator initiated study, to be led by Dr. Hance Clarke and conducted at University Health Network Multi-centre, blinded, randomized placebo-controlled investigator initiated study, to be led by Dr. Han…
TORONTO, May 20, 2025 (GLOBE NEWSWIRE) — Avicanna Inc. (Avicanna or Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing, and commerc…